PCI Pharma Services explores $1 billion sale: Reuters

PCI Pharma Services, a U.S. provider of outsourced packaging and clinical trial supply services to the pharmaceutical industry, is exploring a sale that could value it at around $1 billion, including debt, Reuters News reported.

ByReuters News

8 March 2016•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals North America US Briefs

PCI Pharma Services explores $1 billion sale: Reuters

Frazier Healthcare Partners

RBC Capital Markets

Related articles